# Longevity Health Holdings, Inc.: filings

XAGE · OTC · CIK 1842939 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xage.md) · [Financials](/companies/xage/financials.md) · [Filings](/companies/xage/filings.md) · [Insiders](/companies/xage/insiders.md)

## Reports and events: 99 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 78, 8-K 56, 424B3 35, 3 21, CORRESP 20, SC 13G/A 18, 10-Q 16, UPLOAD 13, SC 13G 12, 8-K/A 6, 10-K 5, 425 5, S-1/A 5, S-4/A 5, D 4, EFFECT 4, NT 10-Q 4, 10-K/A 3, DEF 14A 3, S-1 3, 25-NSE 2, RW 2, S-4 2, SCHEDULE 13G/A 2, 10-Q/A 1, 424B4 1, 424B5 1, 8-A12B 1, ARS 1, CERT 1, DEFA14A 1, DRS 1, NT 10-K 1, POS AM 1, PRE 14A 1, S-3 1, S-8 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-08 | 08:00 ET | [8-K](/filings/0001437749-26-029755.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-029755 |
| 2026-09-04 | 17:03 ET | [8-K](/filings/0001437749-26-029714.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-26-029714 |
| 2026-08-17 | 09:57 ET | [8-K](/filings/0001437749-26-028120.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-028120 |
| 2026-08-14 | 17:02 ET | [10-Q](/filings/0001437749-26-028043.md) | Quarterly report, period 2026-06-30 | 0001437749-26-028043 |
| 2026-08-14 | 16:11 ET | [8-K](/filings/0001437749-26-028011.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-028011 |
| 2026-06-04 | 16:30 ET | [8-K](/filings/0001193125-26-257520.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-257520 |
| 2026-05-15 | 17:53 ET | [10-Q](/filings/0001193125-26-224428.md) | Quarterly report, period 2026-03-31 | 0001193125-26-224428 |
| 2026-04-08 | 21:52 ET | [SCHEDULE 13D](/filings/0001423603-26-000008.md) | Ownership report, active investor | 0001423603-26-000008 |
| 2026-03-31 | 16:30 ET | [10-K](/filings/0001193125-26-134698.md) | Annual report, period 2025-12-31 | 0001193125-26-134698 |
| 2026-03-17 | 08:30 ET | [8-K](/filings/0001193125-26-109472.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-109472 |
| 2025-12-12 | 16:30 ET | [8-K](/filings/0001193125-25-317638.md) | 1.02 Termination of a material agreement | 0001193125-25-317638 |
| 2025-11-14 | 16:30 ET | [10-Q](/filings/0001193125-25-283127.md) | Quarterly report, period 2025-09-30 | 0001193125-25-283127 |
| 2025-11-07 | 17:00 ET | [8-K](/filings/0001193125-25-272538.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-272538 |
| 2025-09-12 | 12:00 ET | [8-K](/filings/0000950170-25-114421.md) | 3.01 Delisting notice | 0000950170-25-114421 |
| 2025-08-14 | 16:31 ET | [10-Q](/filings/0000950170-25-108973.md) | Quarterly report, period 2025-06-30 | 0000950170-25-108973 |
| 2025-07-14 | 16:38 ET | [8-K](/filings/0000950170-25-095608.md) | 1.01 Entry into a material agreement; 5.01 Change in control; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-095608 |
| 2025-06-25 | 17:00 ET | [8-K](/filings/0000950170-25-090015.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-090015 |
| 2025-06-17 | 17:01 ET | [10-K/A](/filings/0000950170-25-087485.md) | Annual report, amended, period 2024-12-31 | 0000950170-25-087485 |
| 2025-05-28 | 18:00 ET | [8-K](/filings/0000950170-25-077905.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-077905 |
| 2025-05-21 | 17:15 ET | [8-K](/filings/0000950170-25-075865.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-075865 |
| 2025-05-16 | 18:08 ET | [8-K](/filings/0000950170-25-072931.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-072931 |
| 2025-05-15 | 17:18 ET | [10-Q](/filings/0000950170-25-072858.md) | Quarterly report, period 2025-03-31 | 0000950170-25-072858 |
| 2025-05-12 | 08:00 ET | [8-K](/filings/0000950170-25-068578.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-068578 |
| 2025-04-14 | 08:03 ET | [8-K](/filings/0000950170-25-053506.md) | 1.01 Entry into a material agreement; 5.01 Change in control; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-053506 |
| 2025-04-03 | 07:00 ET | [8-K](/filings/0000950170-25-049943.md) | 3.01 Delisting notice | 0000950170-25-049943 |
| 2025-03-31 | 17:05 ET | [10-K](/filings/0000950170-25-047891.md) | Annual report, period 2024-12-31 | 0000950170-25-047891 |
| 2025-03-31 | 16:30 ET | [8-K/A](/filings/0000950170-25-047788.md) | 9.01 Financial statements and exhibits | 0000950170-25-047788 |
| 2025-03-26 | 17:00 ET | [8-K](/filings/0000950170-25-045392.md) | 5.07 Shareholder vote results | 0000950170-25-045392 |
| 2025-03-10 | 08:49 ET | [8-K](/filings/0000950170-25-035950.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-035950 |
| 2025-03-05 | 17:00 ET | [8-K](/filings/0000950170-25-033793.md) | 3.01 Delisting notice | 0000950170-25-033793 |
| 2025-02-10 | 17:23 ET | [DEF 14A](/filings/0000950170-25-017159.md) | Proxy statement, period 2025-02-10 | 0000950170-25-017159 |
| 2025-02-10 | 17:01 ET | [DEF 14A](/filings/0000950170-25-017157.md) | Proxy statement, period 2025-02-10 | 0000950170-25-017157 |
| 2025-01-24 | 17:00 ET | [8-K](/filings/0000950170-25-008865.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-008865 |
| 2025-01-16 | 08:00 ET | [8-K](/filings/0000950170-25-006024.md) | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-006024 |
| 2025-01-03 | 17:21 ET | [8-K](/filings/0000950170-25-001359.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-001359 |
| 2024-12-31 | 16:31 ET | [8-K](/filings/0000950170-24-141623.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-141623 |
| 2024-11-20 | 16:30 ET | [8-K](/filings/0000950170-24-129329.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-129329 |
| 2024-11-14 | 07:00 ET | [10-Q](/filings/0000950170-24-126725.md) | Quarterly report, period 2024-09-30 | 0000950170-24-126725 |
| 2024-10-03 | 16:30 ET | [8-K](/filings/0000950170-24-112392.md) | 3.01 Delisting notice | 0000950170-24-112392 |
| 2024-08-30 | 16:30 ET | [8-K](/filings/0000950170-24-102375.md) | 3.01 Delisting notice | 0000950170-24-102375 |
| 2024-08-14 | 16:16 ET | [10-Q](/filings/0000950170-24-097039.md) | Quarterly report, period 2024-06-30 | 0000950170-24-097039 |
| 2024-07-29 | 08:38 ET | [8-K](/filings/0000950170-24-087128.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-087128 |
| 2024-07-17 | 17:19 ET | [8-K](/filings/0000950170-24-084333.md) | 5.07 Shareholder vote results | 0000950170-24-084333 |
| 2024-06-14 | 08:24 ET | [DEF 14A](/filings/0000950170-24-073350.md) | Proxy statement, period 2024-07-12 | 0000950170-24-073350 |
| 2024-05-30 | 16:14 ET | [S-1/A](/filings/0001193125-24-150346.md) | Registration statement, amended | 0001193125-24-150346 |
| 2024-05-15 | 16:21 ET | [10-Q](/filings/0000950170-24-060506.md) | Quarterly report, period 2024-03-31 | 0000950170-24-060506 |
| 2024-05-10 | 16:17 ET | [S-1](/filings/0001193125-24-136185.md) | Registration statement | 0001193125-24-136185 |
| 2024-04-29 | 17:08 ET | [10-K/A](/filings/0000950170-24-050040.md) | Annual report, amended, period 2023-12-31 | 0000950170-24-050040 |
| 2024-04-04 | 17:28 ET | [8-K](/filings/0000950170-24-041908.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-041908 |
| 2024-04-01 | 16:47 ET | [8-K](/filings/0000950170-24-039431.md) | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-039431 |

Page 1 of 2. [Older](/companies/xage/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.